Stability and Stabilization Studies of TAK-599 (Ceftaroline Fosamil), a Novel N-Phosphono Type Prodrug of Anti-methicillin Resistant Staphylococcus aureus Cephalosporin T-91825

TAK-599 (known as ceftaroline fosamil) is a novel N-phosphono type prodrug of a cephalosporin compound, T-91825, that exhibits strong activity against methicillin resistant Staphylococcus aureus (MRSA). The stability and stabilization of TAK-599 were investigated by kinetic analysis focused on cryst...

Full description

Saved in:
Bibliographic Details
Published in:Chemical & Pharmaceutical Bulletin Vol. 56; no. 10; pp. 1406 - 1411
Main Authors: Yukihiro IKEDAa, Junko BANa, Tomoyasu ISHIKAWAa, Shohei HASHIGUCHIa, Shinichi URAYAMAb, Hidetoshi HORIBEa
Format: Journal Article
Language:Japanese
Published: Pharmaceutical Society of Japan 2008
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract TAK-599 (known as ceftaroline fosamil) is a novel N-phosphono type prodrug of a cephalosporin compound, T-91825, that exhibits strong activity against methicillin resistant Staphylococcus aureus (MRSA). The stability and stabilization of TAK-599 were investigated by kinetic analysis focused on crystallinity and moisture content. Initially it was planned to develop TAK-599 as an injectable formulation using the amorphous solid powder prepared by lyophilization. However, amorphous of TAK-599 free form was found to be chemically unstable even when stored at 8℃, and thus development was focused on the crystalline material. After exhaustive screening of crystallization condition, the monoacetic acid solvate was found to yield TAK-599 in a crystalline form. Physicochemical properties were studied to identify the key factors affecting the stabilization of TAK-599 in order to improve long-term stability, and the results indicated that the crystallinity of TAK-599 correlated with stability. Furthermore, moisture content was also identified in our studies as an important factor in stabilizing TAK-599. TAK-599 containing about 3% moisture was found to be the most stable form. It was concluded that both sufficient crystallinity and strict moisture control of TAK-599 were essential to maintain long-term stability at 25℃.
AbstractList TAK-599 (known as ceftaroline fosamil) is a novel N-phosphono type prodrug of a cephalosporin compound, T-91825, that exhibits strong activity against methicillin resistant Staphylococcus aureus (MRSA). The stability and stabilization of TAK-599 were investigated by kinetic analysis focused on crystallinity and moisture content. Initially it was planned to develop TAK-599 as an injectable formulation using the amorphous solid powder prepared by lyophilization. However, amorphous of TAK-599 free form was found to be chemically unstable even when stored at 8℃, and thus development was focused on the crystalline material. After exhaustive screening of crystallization condition, the monoacetic acid solvate was found to yield TAK-599 in a crystalline form. Physicochemical properties were studied to identify the key factors affecting the stabilization of TAK-599 in order to improve long-term stability, and the results indicated that the crystallinity of TAK-599 correlated with stability. Furthermore, moisture content was also identified in our studies as an important factor in stabilizing TAK-599. TAK-599 containing about 3% moisture was found to be the most stable form. It was concluded that both sufficient crystallinity and strict moisture control of TAK-599 were essential to maintain long-term stability at 25℃.
Author Junko BANa
Yukihiro IKEDAa
Hidetoshi HORIBEa
Tomoyasu ISHIKAWAa
Shohei HASHIGUCHIa
Shinichi URAYAMAb
Author_xml – sequence: 1
  fullname: Yukihiro IKEDAa
– sequence: 2
  fullname: Junko BANa
– sequence: 3
  fullname: Tomoyasu ISHIKAWAa
– sequence: 4
  fullname: Shohei HASHIGUCHIa
– sequence: 5
  fullname: Shinichi URAYAMAb
– sequence: 6
  fullname: Hidetoshi HORIBEa
BookMark eNotUNFKwzAU7cME59w_5FHBQNK0SfM4hlNxzKH1uWRJaiNpUppUmF_lJ5rpXu7hwL3nnHuuspnzTs-yOUKIw5xQcpktQzAHlBNcUl4V8-znLYqDsSYegXAKnNm3iMa7xCZldAC-BfXqGZacg5u1bqMYvTVOg40Pojf29g4IsPNf2oId3Hc-DJ13HtTHQYP96NU4fZwkVi4a2OvYGWlsugevOpgQhYsn26E7Wi-9lFMAYhp1grUeOmGTnB_Tdg05rvLyOrtohQ16ecZF9r65r9ePcPvy8LRebWGPSV5BRjhiuSRKFxyVlCquWIkkqgjmhOJSK8YVlQUTTKkDVpSnSjjjLUcaY0nJItv86_ZaGZliuNPLzaefRpd8GxmY7HRvmhyhqkHJA6MEtMHF38A4J4ymzn8BIuJ3TA
ContentType Journal Article
CorporateAuthor bPharmaceutical Production Division Takeda Pharmaceutical Company Ltd
aPharmaceutical Research Division Takeda Pharmaceutical Company Ltd
CorporateAuthor_xml – name: aPharmaceutical Research Division Takeda Pharmaceutical Company Ltd
– name: bPharmaceutical Production Division Takeda Pharmaceutical Company Ltd
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EndPage 1411
ExternalDocumentID cs7chemi_2008_005610_006_1406_1411237636
GroupedDBID ---
.55
.GJ
29B
2WC
3O-
53G
5GY
6J9
ABTAH
ACGFO
ACIWK
ACPRK
ADBBV
AENEX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKOMP
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
HH5
JMI
JSF
JSH
KQ8
L7B
MOJWN
OK1
P2P
RJT
RZJ
TKC
TR2
VH1
X7J
X7M
XSB
ZE2
ZGI
ZY4
ID FETCH-LOGICAL-m1328-739072c3de490566d9d750c083193615ed79d6c47a7ddb1d69315979f90e11c63
ISSN 0009-2363
IngestDate Fri Nov 08 06:52:50 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-m1328-739072c3de490566d9d750c083193615ed79d6c47a7ddb1d69315979f90e11c63
PageCount 6
ParticipantIDs medicalonline_journals_cs7chemi_2008_005610_006_1406_1411237636
PublicationCentury 2000
PublicationDate 20080000
PublicationDateYYYYMMDD 2008-01-01
PublicationDate_xml – year: 2008
  text: 20080000
PublicationDecade 2000
PublicationTitle Chemical & Pharmaceutical Bulletin
PublicationYear 2008
Publisher Pharmaceutical Society of Japan
Publisher_xml – name: Pharmaceutical Society of Japan
SSID ssib023156984
ssib014648066
ssj0025073
ssib002822113
ssib017383858
Score 1.9143877
Snippet TAK-599 (known as ceftaroline fosamil) is a novel N-phosphono type prodrug of a cephalosporin compound, T-91825, that exhibits strong activity against...
SourceID medicalonline
SourceType Publisher
StartPage 1406
Title Stability and Stabilization Studies of TAK-599 (Ceftaroline Fosamil), a Novel N-Phosphono Type Prodrug of Anti-methicillin Resistant Staphylococcus aureus Cephalosporin T-91825
URI http://mol.medicalonline.jp/en/journal/download?GoodsID=cs7chemi/2008/005610/006&name=1406-1411e
Volume 56
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9owELZYnzZN035qXbvJD1u1KVgiJCTx05RROigSQmqq7Q0F21FYSzwRMon_an_i7hITkj51mvZAAJMY8H06313uviPk_RJ7N4gkZrD5JMy1VZ_xpS1YopSdeAG4PjHWDo-v_Nn34HzkjjqdPQ_xYey_ShrGQNZYOfsX0q4nhQF4DTKHI0gdjveSO1iPZb5rxatk3lW1lvukQTQQo3DKBpyXN3FVsq2a9yjrQucY8fjQ52VapzXTv9StNWPzVOeYxa4tdFyxvEBuijJdOsy2K4Z9qFcCQzflDQG0SbMtfjkIEXZLLUSRW3GxUfA0VD_T-FajOw1nR6AHg6oouSZM2HMYICrnaSvm3mILL_uJ3azS1UZbk-noPKy3mMsiu9HWl3BWj0R6rXdxXlgYoJuG3w7nXqU6VStrHMIHX6-H40ncioQENWrv_JR9viuswSVYHFlL_3PWd4xKNfq_Ijbf47zX0ObgfHoNy8B2zb7QJugWuS9wYUxHT3TJkHLVW-DlC7wIM48cpIV3QaWi4T6ZNl1e8MFrHQkblxs0GPZt3wmafENgjg88jrXFJqgA9nzdLRD_2SPyeF3d4quoVhrWUvSUPDFuDg0rfD4jnR_xc3JmVnDXpdGh7C_v0jM6PzCo716Q3zWIKYCYtkBMDYipTqgBMf3YgDA1EP7UpTEt4Usb8KUIX2rgi1PchS-t4Uvb8KUVfGkLvtTA9yW5vhhFwzEzrUXY2nb6AfMd3vP7wpHK5SAwT3IJprPAtnvcASNfSZ9LT7h-7Eu5tKXHYd25zxPeU7YtPOcVOcp0pl4TKnhSksaBJSxdX7qBdHkyiGN4yIFwnGPyuSWQhVEW-eK-wHnzzzOckIdVnhOGDk_J0XZTqLfkQS6LdyUa_wAa_crJ
link.rule.ids 315,782,786,4030
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stability+and+Stabilization+Studies+of+TAK-599+%28Ceftaroline+Fosamil%29%2C+a+Novel+N-Phosphono+Type+Prodrug+of+Anti-methicillin+Resistant+Staphylococcus+aureus+Cephalosporin+T-91825&rft.jtitle=Chemical+%26+Pharmaceutical+Bulletin&rft.au=Yukihiro+IKEDAa&rft.au=Junko+BANa&rft.au=Tomoyasu+ISHIKAWAa&rft.au=Shohei+HASHIGUCHIa&rft.date=2008&rft.pub=Pharmaceutical+Society+of+Japan&rft.issn=0009-2363&rft.volume=56&rft.issue=10&rft.spage=1406&rft.epage=1411&rft.externalDocID=cs7chemi_2008_005610_006_1406_1411237636
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon